Cargando…

伴Ph染色体变异易位初诊慢性髓性白血病慢性期患者的细胞、分子遗传学特征及酪氨酸激酶抑制剂疗效

OBJECTIVE: To investigate the molecular-cytogenetic characterization and impact on tyrosine kinase inhibitors (TKIs) therapy in chronic phase of chronic myeloid leukemia (CML-CP) patients with variant Ph chromosome (vPh). METHODS: The clinical data of 32 patients with vPh chromosomes were collected...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343003/
https://www.ncbi.nlm.nih.gov/pubmed/29562466
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.008